Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia.
Health Company Announces Out-License Deal With Bioscience Firm For Schizophrenia Drug Candidate
Health Company Announces Out-License Deal…
Health Company Announces Out-License Deal With Bioscience Firm For Schizophrenia Drug Candidate
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia.